Drugs & TargetsFree FDA approves treatment to reduce risk of breast cancer returning July 21, 2017Vol.43 No.29
Drugs & TargetsFree FDA accepts for priority review BMS application for dasatinib in children with CP Ph+ CML July 21, 2017Vol.43 No.29
Drugs & Targets FDA converts accelerated approval of Amgen’s Blincyto to full approval in ALL July 14, 2017Vol.43 No.28
Drugs & Targets FDA places clinical hold on Merck’s three Keytruda multiple myeloma studies July 14, 2017Vol.43 No.28
Drugs & TargetsFree FDA clears cooling cap treatment in solid tumor chemotherapy July 07, 2017Vol.43 No.27
Drugs & TargetsFree FDA granted marketing approval to the Praxis Extended RAS Panel July 07, 2017Vol.43 No.27
Drugs & TargetsFree FDA approves Endari for patients with sickle cell disease July 07, 2017Vol.43 No.27
Drugs & Targets FDA approves Vectibix for use in wild-type ras metastatic colorectal cancer July 06, 2017Vol.40 No.06
Drugs & Targets FDA approves Vectibix for use in wild-type ras metastatic colorectal cancer June 30, 2017Vol.43 No.26
Drugs & Targets FDA approves flow cytometry test for leukemias and lymphomas June 30, 2017Vol.43 No.26
